From the MeOH extract of the heartwood of Artocapus altilis, thirteen phenolic compounds have been isolated, namely curcumin (1), desmethoxycurcumin (2), retrodihydrochalcone (3), apigenin (4), tangeretin (5), nobiletin (6), O-methyldehydrodieugenol (7), dehydrodieugenol (8), β-hydroxypropiovanillone (9), p-coumaric acid (10), p-hydroxybenzaldehyde (11), vanillin (12), and vanillic acid (13). This is the first report on the presence of these compounds in the heartwood of A. altilis. Compounds 1, 2, and 10 showed more potent tyrosinase inhibitory activities, with IC 50 values ranging from 2.3 to 42.0 μM, than the positive control kojic acid (IC 50 , 44.6 μM). The most active compound, p-coumaric acid (10) (IC 50 , 2.3 μM), was 22 times more active in tyrosinase inhibitory activity than kojic acid.
Tyrosinase (EC 1.14.18.1) is known to be a key enzyme in melanin biosynthesis, involved in determining the color of mammalian skin and hair. Various dermatological disorders, such as melasma, age spots and sites of actinic damage, arise from the accumulation of an excessive level of epidermal pigmentation. In addition, unfavorable enzymatic browning of plant-derived foods by tyrosinase causes a decrease in nutritional quality and economic loss of food products [1] . Thus, the use of tyrosinase inhibitors can prevent overproduction of melanin in human epidermal layers, as well as preserve many food products.
Artocapus altilis (Parkinson) Fosberg (Moraceae), known as breadfruit, is widely distributed in tropical and subtropical regions of Asia, including Vietnam, and has been used as an antiinflammatory, antioxidant, antidiabetes, and anti-aging agent [2] . Previously, prenylflavonoids, xanthones and stilbens have been isolated from the root and stem bark of the plant [3] [4] [5] . As part of our search for biologically active compounds with utility against overproduction of melanin in human epidermal layers, we initiated a screen to evaluate natural product extracts for the inhibition of tyrosinase. A methanolic extract of the heartwood of A. altilis showed significant tyrosinase inhibitory activity with an IC 50 value of 24.0 μg/mL. Thus, we examined the constituents of this plant and isolated thirteen known compounds (1-13), including flavonoids, curcuminoids, dihydrochalcone, and simple phenolics. In this paper, we report the isolation and tyrosinase inhibitory activity of the isolated compounds.
The methanolic extract of the heartwood of A. altilis was partitioned into EtOAc and H 2 O fractions. The EtOAc fraction was subjected to a series of chromatographic separation to afford thirteen known compounds. These compounds were identified by analysis of their spectroscopic data to be curcumin (1) [6] , desmethoxycurcumin (2) [6] , retrodihydrochalcone (3) [7] , apigenin (4) [8] , tangeretin (5) [9] , nobiletin (6) [9] , O-methyldehydrodieugenol (7) [10, 11] , dehydrodieugenol (8) [12] , β-hydroxypropiovanillone (9) [13] , p-coumaric acid (10) [14] , p-hydroxybenzaldehyde (11) [14] , vanillin (12) [14] , and vanillic acid (13) [14] (Figure 1 ). This is the first report on the presence of these compounds in the heartwood of A. altilis. All of the isolated compounds, except for 3 and 4, were examined for their tyrosinase inhibitory activity (Table 1) . Compounds 1, 2, and 10 showed more potent activities than the positive control, kojic acid (IC 50 , 44.6 μM), a well known tyrosinase inhibitor, currently used as a cosmetic skin-whitening agent [1]. The most active compound, p-coumaric acid (10) (IC 50 , 2.3 μM), was 22 times more active in tyrosinase inhibitory activity than kojic acid. These results suggest that A. altilis heartwood extract or some of its constituents could be promising natural agents to counteract tyrosinase activity in cosmetic and food products, this warrants further investigation. (4:6) to give 10 (20.0 mg), 3 (2.0 mg) and 4 (2.0 mg). Fraction 5 was subjected to silica gel CC, eluted with MeOH/CHCl 3 (0 -30%) to afford 3 subfractions (5-1, 450 mg; 5-2, 150 mg; and 5-3, 220 mg). Subfraction 5-1 was separated by reversed-phase preparative TLC with acetone/H 2 O (7:3) to give 7 (26.0 mg). Subfraction 5-2 was rechromatographed with an acetone/n-hexane gradient system, followed by normal-phase preparative TLC with MeOH/CHCl 3 (1:99) to afford 8 (8.5 mg). Subfraction 5-3 was applied to normalphase preparative TLC with MeOH/CHCl 3 (1:99) to obtain 5 (7.0 mg) and 6 (10.0 mg).
Tyrosinase inhibitory assay:
All the samples were dissolved in DMSO and used at concentrations of 100, 50, 25, 10 µg/mL (or µM for pure compounds). The tyrosinase inhibitory activity assay was performed as previously described by Arung et al. [15] . The assay mixture, consisting of 1900 µL of test solution in 0.1 M phosphate buffer, pH 6.8, and 100 µL of enzyme solution (15 U/mL in 0.1 M phosphate buffer pH 6.8) was prepared immediately before use. After preincubation at room temperature for 30 min, the reaction was initiated by the addition of 1000 µL of substrate solution (1.5 mM L-dihydroxyphenylalanine in 0.1 M phosphate buffer, pH 6.8). The assay mixture was incubated at room temperature for 7 min and the absorbance at 480 nm was measured with a Shimadzu UV-1800 spectrophotometer.
Tyrosinase inhibitory activity was expressed as the percentage inhibition of tyrosinase in the above assay system, calculated as (1-B/A)×100, where A and B are the activities of the enzyme without and with test material. IC 50 values were calculated from the mean values of data from 3 determinations. Kojic acid, a known tyrosinase inhibitor, was used as positive control.
